谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Semaglutide 2.4 Mg Once Weekly Improved Liver and Metabolic Parameters, and Was Well Tolerated, in Patients with Non-Alcoholic Steatohepatitis-Related Cirrhosis: a Randomised, Placebo-Controlled Phase 2 Trial

Rohit Loomba,Manal F. Abdelmalek,Matthew J. Armstrong,Maximilian Jara,Mette Skalshoi Kjaer,Niels Krarup,Eric Lawitz,Vlad Ratziu,Arun J. Sanyal,Jorn M. Schattenberg,Philip N. Newsome

LANCET GASTROENTEROLOGY & HEPATOLOGY（2023）

引用 2|浏览0
暂无评分
关键词
Liver Cirrhosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要